Condition
    Strong Evidence
    Effectiveness 3/5

    Vitamin D for Menopause

    Vitamin D matters for postmenopausal bone health when combined with calcium, but it does not improve hot flashes and monotherapy fracture data are weak.

    Overview

    Vitamin D matters for postmenopausal bone health when combined with calcium, but it does not improve hot flashes and monotherapy fracture data are weak.

    Verdict

    Mixed evidence

    How It Works

    Vitamin D drives intestinal calcium absorption and suppresses secondary hyperparathyroidism, which limits the bone resorption accelerated by estrogen withdrawal.

    Dosing & Protocol

    Typical dose

    Recommended dose
    2000-4000 IU daily (target 40-60 ng/mL)
    Expected timeframe
    Months to years for bone outcomes; no effect on vasomotor symptoms

    Protocol

    form
    Vitamin D3 (cholecalciferol), often combined with calcium in bone-health formulations
    duration
    Long-term, as bone protection through and after the menopause transition
    co factor
    Take with the largest meal. The distinction matters: vitamin D with calcium supports bone mineral density and, with adequate calcium, modestly reduces fracture risk in older adults - that is the real indication around menopause, when bone loss accelerates. Vitamin D does not improve hot flushes, night sweats or other vasomotor symptoms, and the Women Health Initiative found no effect on those.
    titration
    Check 25-hydroxyvitamin D and target 75-125 nmol/L; do not exceed 4000 IU/day without supervision
    starting dose
    800-2000 IU (20-50 mcg) vitamin D3 daily with a fat-containing meal, alongside 1000-1200 mg total daily calcium from diet where possible

    Evidence

    What the studies say

    The Womens Health Initiative and later meta-analyses show fracture benefit mainly for vitamin D plus calcium in deficient or institutionalised women. VITAL found no benefit of high-dose vitamin D alone on fractures in replete adults.

    No studies are yet linked to both Vitamin D and Menopause.

    Safety

    Caveats

    Vitamin D is not a treatment for menopausal symptoms - hormone therapy is the most effective option for vasomotor symptoms in those who can take it, with non-hormonal prescription alternatives available. Any postmenopausal bleeding needs urgent investigation. Safety ceiling: the tolerable upper intake level is 4000 IU (100 mcg) per day; excess causes hypercalcaemia, kidney stones and kidney injury, and very high intermittent bolus dosing has increased falls and fractures in trials. Calcium supplements above dietary needs carry their own cardiovascular and kidney stone debate - prioritise dietary calcium. Avoid unsupervised use in sarcoidosis, granulomatous disease and primary hyperparathyroidism. Interacts with thiazide diuretics and digoxin.

    Less likely to help if

    Women seeking relief from hot flushes or night sweats, for whom vitamin D has no demonstrated effect.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.